Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael A. Amantea"'
Publikováno v:
Cancer Chemotherapy and Pharmacology. 43:1-7
Purpose: The pharmacokinetics (PK), biodistribution and therapeutic efficacy of cisplatin encapsulated in long-circulating pegylated (Stealth®) liposomes (SPI-077) were compared with those of nonliposomal cisplatin in two murine (C26 colon carcinoma
Publikováno v:
Clinical Pharmacology & Therapeutics. 61:301-311
Objective To characterize the population pharmacokinetics of pegylated-liposomal doxorubicin in patients with acquired immunodeficiency disease (AIDS)-related Kaposi's sarcoma and to explore the relationship between response of the cutaneous Kaposi's
Autor:
J Lavelle, Michael A. Amantea, A Morgan, D Ogata-Arakaki, K Ownby, Judith Falloon, A Graziani, Michael A. Polis, A Byrne, Richard T. Davey
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:1580-1587
The safety and pharmacokinetics of weekly dapsone and weekly dapsone plus pyrimethamine were examined in adult patients with human immunodeficiency virus infection who were at risk for pneumocystis pneumonia because of a prior episode or a CD4+ T-cel
Autor:
Harold Frucht, Jerry D. Gardner, Rakesh Vinayek, Michael A. Amantea, Robert T. Jensen, Paul N. Maton
Publikováno v:
Gastroenterology. 101:138-147
The pharmacokinetics and pharmacodynamics of oral and IV omeprazole after a single dose were studied in 9 patients with the Zollinger-Ellison syndrome to determine whether the increased dose required to control gastric acid hypersecretion could be ex
Autor:
Hai-Zhi Bu, Bhasker V. Shetty, Susan R. Raber, William F. Pool, Ellen Y. Wu, Michael A. Amantea
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 32(7)
Metabolism and disposition of capravirine, a new non-nucleoside reverse transcriptase inhibitor, were studied in healthy male volunteers who were randomly divided into two groups (A and B) with five subjects in each group. Group A received a single o
Autor:
Michael A. Amantea, Raleigh A. Bowden, Alan Forrest, Peter K. Working, Mary S. Newman, Richard D. Mamelok
Publikováno v:
Chemotherapy. 45
The purpose of this study was to identify the pharmacokinetics of Amphotericin B Colloidal Dispersion in patients undergoing bone marrow transplantations with systemic fungal infections and to assess the influence of ABCD on renal function. Seventy-f
Autor:
Michael A. Amantea
Publikováno v:
American Journal of Health-System Pharmacy. 47:1129-1131
Publikováno v:
The Journal of antimicrobial chemotherapy. 40
This analysis was designed to characterize the population pharmacokinetics and pharmacodynamics of oral grepafloxacin (OPC-17,116) in patients with acute bacterial exacerbations of chronic bronchitis (ABECB). The study group included 76 patients (43
Publikováno v:
The Annals of pharmacotherapy. 30(7-8)
OBJECTIVE: To evaluate the antiemetic efficacy of a modified regimen of oral ondansetron and dexamethasone in patients with lupus nephritis undergoing treatment with cyclophosphamide whose conventional antiemetic regimen had failed. DESIGN: A before-
Autor:
James W. Lee, Michael A. Amantea, Eileen Navarro, Thomas J. Walsh, John Bacher, Philip A. Pizzo, P A Francis
A unilamellar liposomal formulation of amphotericin B (LAmB) known as AmBisome was safely administered intravenously to 20 rabbits at 0.5, 1.0, 2.5, 5, or 10 mg/kg of body weight, whereas of 12 rabbits given desoxycholate amphotericin B (DAmB) intrav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3374558f686c811da8a03e22ea3f883b
https://europepmc.org/articles/PMC284530/
https://europepmc.org/articles/PMC284530/